FDA Approves Xarelto (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients

RARITAN, N.J., October 14, 2019– The Janssen Pharmaceutical Companies of Johnson& Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news